Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6026.5000
11.00
(
0.18
%)
NSE
Sep 12, 2025
15:31 PM
Volume:
487.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2023
6026.50
0.18%
Lower realization in API sales/ reduced operating leverage drag earnings
Neutral:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 2620
Recommendation
Target
Motilal Oswal
Deven Choksey released a Accumulate report for Divi's Laboratories Ltd. with a price target of 6499.0 on 29 Aug, 2025.
More from Divi's Laboratories Ltd.
Recommended
Five Interesting Stocks Today - September 12, 2025
The Baseline |
12 Sep 2025, 04:39PM
Market closes higher, Hindustan Copper announces a Rs 2,000 crore capex
Trendlyne Marketwatch |
12 Sep 2025, 04:00PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022